Albireo Pharma, Inc.November 30th, 2022
FiledNovember 30th, 2022We have entered into a Sales Agreement, or sales agreement, with Cowen and Company, LLC, or Cowen, dated August 15, 2022, relating to the sale of shares of our common stock offered by this prospectus. In accordance with the terms of the sales agreement, under this prospectus we may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to
Albireo Pharma, Inc.December 5th, 2019
FiledDecember 5th, 2019We have entered into a Sales Agreement, or sales agreement, with Cowen and Company, LLC, or Cowen, dated October 13, 2017, relating to the sale of shares of our common stock offered by this prospectus. In accordance with the terms of the sales agreement, under this prospectus we may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to $50,000,000 from time to time through Cowen, acting as our agent.